CAS: 2283-82-1 - Dehydroandrosterone
Formula:C19H28O2
InChI:InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14+,15+,16+,18+,19+/m1/s1
InChI key:InChIKey=FMGSKLZLMKYGDP-HKQXQEGQSA-N
SMILES:O=C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C
- Synonyms:
- (3Alpha)-3-Hydroxyandrost-5-En-17-One
- (3α)-3-Hydroxyandrost-5-en-17-one
- 3-alpha-Hydroxyandrost-5-ene-17-one
- 3α-Hydroxy-5-androsten-17-one
- Androst-5-en-17-one, 3-hydroxy-, (3α)-
- Androst-5-en-17-one, 3α-hydroxy-
- Androst-5-en-3α-ol-17-one
- Isoandrostenolone
- Δ5-Androstene-3α-ol-17-one
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Dehydroandrosterone REF: 7W-GK9454CAS: 2283-82-1 | - - - | To inquire | Tue 28 May 24 |
 | Dehydro Androsterone REF: 4Z-A-8264CAS: 2283-82-1 | - - - | To inquire | Tue 28 May 24 |
 | Dehydro Androsterone REF: TR-D229165CAS: 2283-82-1 | - - - | 183.00 €~1,264.00 € | Tue 04 Jun 24 |
 | 5-Androsten-3a-ol-17-one REF: 3D-FA46908CAS: 2283-82-1 | Min. 95% | To inquire | Mon 08 Jul 24 |
Ref: 4Z-A-8264
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 May 2024
Dehydro Androsterone
CAS:2283-82-1
Applications Dehydro Androsterone is an Androsterone (A637535) analogue. References Amann, R., et al.: Life Sci., …
Formula:
C19H28O2
Color and Shape:
Off-White
Molecular weight:
288.42
Ref: TR-D229165
| 10mg | 183.00 € | |
| 50mg | 720.00 € | |
| 100mg | 1,264.00 € |
Estimated delivery in United States, on Tuesday 4 Jun 2024
5-Androsten-3a-ol-17-one
Controlled ProductCAS:2283-82-1
5-Androsten-3a-ol-17-one is a naturally occurring hormone that has been shown to have potent antagonist activity …
Formula:
C19H28O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
288.42 g/mol
Ref: 3D-FA46908
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire | |
| 500mg | To inquire |
Estimated delivery in United States, on Monday 8 Jul 2024
